Endoscopic Ultrasound-Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction

NCT ID: NCT04810377

Last Updated: 2025-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Malignant gastric outlet obstruction is a very disabling complication of patients with gastric, duodenal, ampullary, pancreatic, or bile duct cancer and worsens their prognosis. Current treatments have reported a similar complication rate and higher mortality in surgically treated patients. Recently, the creation of endoscopic ultrasound-guided gastroenterostomy (EUS) has shown promising results in these patients. The aim of this research is to determine the safety and efficacy of EUS-guided gastro-enterostomy in the treatment of patients with malignant gastric outlet obstruction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Malignant gastric outlet obstruction is a very disabling complication that occurs in 15% to 25% of patients with gastric, duodenal, ampullary, pancreatic, or bile duct cancer and worsens their prognosis. Roux-en-Y gastrojejunostomy is considered the gold standard treatment with technical success of 98.6% (97-3% -99.9%) and clinical success of 80.1% with patency of 169.2 (136.8-201.7) days. On the other hand, the technical success reported for self-expanding metal stents is 96.2% (94.1% vs. 98.4%), technical success is 79.4%, and patency at 6 months was only 57%. However, complications occur in a similar way in both forms of treatment (major complications in 6% and late complications in 17% in both, but mortality is higher in the group treated with Roux-en-Y gastrojejunostomy (29% vs. 17%). , p \<0.001) Recently, the creation of endoscopic ultrasound-guided gastroenterostomy has shown success rates of over 90% in case series, but prospective studies evaluating the safety and efficacy of the procedure are lacking. The aim of this research to determine the safety and efficacy of EUS-guided gastro-enterostomy in the treatment of patients with malignant gastric outlet obstruction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Gastric Outlet Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a prospective study that evaluates EUS-guided gastroenterostomy in a group of participants with diagnosis of malignant gastric outlet obstruction. Patients are sequentially recruited as diagnosed.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EUS-guided gastroenterostomy in malignant gastric outlet obstruction

The patients with malignant gastric outlet obstruction will be confirmed as follows: Histopathological report of cancer, thoracoabdominal tomography and impaired tolerance to oral feeding (tolerance to liquids only or null).

Group Type EXPERIMENTAL

EUS-guided gastroenterostomy

Intervention Type PROCEDURE

First after an upper endoscopy is performed, a catheters passed throughout the endoscope channel and with x-ray verification, a guide wire is passed up to the third portion of duodenal loop. then small intestinal is filled with saline solution up to 1500cc and contrast solution. Then an endoscopic ultrasound examination will be carried out where a loop of the small intestine that is located less than 2 cm apart from the gastric wall will be looked for. Once the intestinal loop is identified a direct antegrade puncture will be performed with a luminal apposition prosthesis release system . Finally, correct position is verified with x-ray and we will look for any misplacement or leakage during this process or the presence of bleeding. Endoscopic treatment will be performed if necessary. Subsequently, the participants will go to monthly follow-up with clinical evaluation, laboratory and radiological test will be carried out until the participants dies.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EUS-guided gastroenterostomy

First after an upper endoscopy is performed, a catheters passed throughout the endoscope channel and with x-ray verification, a guide wire is passed up to the third portion of duodenal loop. then small intestinal is filled with saline solution up to 1500cc and contrast solution. Then an endoscopic ultrasound examination will be carried out where a loop of the small intestine that is located less than 2 cm apart from the gastric wall will be looked for. Once the intestinal loop is identified a direct antegrade puncture will be performed with a luminal apposition prosthesis release system . Finally, correct position is verified with x-ray and we will look for any misplacement or leakage during this process or the presence of bleeding. Endoscopic treatment will be performed if necessary. Subsequently, the participants will go to monthly follow-up with clinical evaluation, laboratory and radiological test will be carried out until the participants dies.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both genders over 18 years of age with gastric outlet obstruction syndrome secondary to stage III or more at gastric, duodenal or pancreatic cancer who are candidates for palliative treatment, who do not want surgical treatment.

* Diagnosis confirmed as follows:

* Histopathological report of cancer.
* Simple and contrasted thoracoabdominal tomography.
* Tolerance to oral feeding based on liquids only or null.

Exclusion Criteria

* Patients who do not accept the signing of the informed consent.

* Postoperative patients with Roux-en-Y gastrojejunostomy.
* Patients with large volume ascites.
* Patients with malignant obstruction distal to the jejunal puncture.
* Pregnant women.
* Patients with a Karnofsky index less than 50 or an E.C.O.G. greater than or equal to 4 points.
* Patients in whom any endoscopic procedure has been contraindicated for any reason.
* Patients who want to undergo surgical treatment as an initial option.
* Patients with malignant biliary obstruction without endoscopic treatment at the time of gastric outflow tract obstruction presentation.

Elimination Criteria:

* Patients who undergo the endoscopic procedure but cannot be completed due to transmural invasion of malignancy, hemorrhage or inability to puncture the intestinal loop with any method described, puncture site\> 2cm away from the gastric wall or inability to pass the guidewire through obstruction (unless direct technique is performed).
* Patients who do not attend follow-up.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oscar V Hernández Mondragón, MD

Role: PRINCIPAL_INVESTIGATOR

IMSS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro Medico Nacional Siglo XXI Hospital de Especialidades

Mexico City, Mexico City, Mexico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Mexico

References

Explore related publications, articles, or registry entries linked to this study.

Suder-Castro LS, Ramirez-Solis ME, Hernandez-Guerrero AI, de la Mora-Levy JG, Alonso-Larraga JO, Hernandez-Lara AH. Predictors of self-expanding metallic stent dysfunction in malignant gastric outlet obstruction. Rev Gastroenterol Mex (Engl Ed). 2020 Jul-Sep;85(3):275-281. doi: 10.1016/j.rgmx.2019.07.009. Epub 2020 Mar 27. English, Spanish.

Reference Type BACKGROUND
PMID: 32229056 (View on PubMed)

Lundstrom B, Fagerberg G. Clinical problems in relation to breast cancer screening with mammography. A preliminary report. Acta Chir Scand Suppl. 1984;519:61-3.

Reference Type BACKGROUND
PMID: 6595925 (View on PubMed)

Metges PJ, Cosnard G, Pailler JL, Chantome M, Flageat J. [Trapped popliteal artery. Early diagnosis by dynamic tests during arteriography (author's transl)]. J Radiol. 1981 May;62(5):331-3. French.

Reference Type BACKGROUND
PMID: 7288729 (View on PubMed)

Storm AC, Ryou M. Advances in the endoscopic management of gastric outflow disorders. Curr Opin Gastroenterol. 2017 Nov;33(6):455-460. doi: 10.1097/MOG.0000000000000403.

Reference Type BACKGROUND
PMID: 28984645 (View on PubMed)

Laasch HU, Martin DF, Maetani I. Enteral stents in the gastric outlet and duodenum. Endoscopy. 2005 Jan;37(1):74-81. doi: 10.1055/s-2004-826103. No abstract available.

Reference Type BACKGROUND
PMID: 15657863 (View on PubMed)

Balderramo DC. [Gastric outlet obstruction]. Rev Esp Enferm Dig. 2008 Feb;100(2):98-9. doi: 10.4321/s1130-01082008000200007. No abstract available. Spanish.

Reference Type BACKGROUND
PMID: 18366268 (View on PubMed)

Chandrasegaram MD, Eslick GD, Mansfield CO, Liem H, Richardson M, Ahmed S, Cox MR. Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction. Surg Endosc. 2012 Feb;26(2):323-9. doi: 10.1007/s00464-011-1870-3. Epub 2011 Sep 5.

Reference Type BACKGROUND
PMID: 21898024 (View on PubMed)

Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD; Dutch SUSTENT Study Group. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010 Mar;71(3):490-9. doi: 10.1016/j.gie.2009.09.042. Epub 2009 Dec 8.

Reference Type BACKGROUND
PMID: 20003966 (View on PubMed)

Beltcheva I, Stoytchev T. Central depressive action of two N-aminomethyl derivatives of diethylpyridinedione. Acta Physiol Pharmacol Bulg. 1983;9(1):35-43.

Reference Type BACKGROUND
PMID: 6684873 (View on PubMed)

Ucar K. The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun. 1991 May 31;177(1):545-50. doi: 10.1016/0006-291x(91)92018-f.

Reference Type BACKGROUND
PMID: 1904222 (View on PubMed)

Espinel J, Vivas S, Munoz F, Jorquera F, Olcoz JL. Palliative treatment of malignant obstruction of gastric outlet using an endoscopically placed enteral Wallstent. Dig Dis Sci. 2001 Nov;46(11):2322-4. doi: 10.1023/a:1012378509762.

Reference Type BACKGROUND
PMID: 11713929 (View on PubMed)

Phillips MS, Gosain S, Bonatti H, Friel CM, Ellen K, Northup PG, Kahaleh M. Enteral stents for malignancy: a report of 46 consecutive cases over 10 years, with critical review of complications. J Gastrointest Surg. 2008 Nov;12(11):2045-50. doi: 10.1007/s11605-008-0598-4. Epub 2008 Jul 22.

Reference Type BACKGROUND
PMID: 18648893 (View on PubMed)

Meylan J, Schindler AM, Kaji T. [Hormonal balance in 2 cases of testicular feminization]. Gynakol Rundsch. 1973;13:Suppl 1:66-7. No abstract available. French.

Reference Type BACKGROUND
PMID: 4798937 (View on PubMed)

Jang S, Stevens T, Lopez R, Bhatt A, Vargo JJ. Superiority of Gastrojejunostomy Over Endoscopic Stenting for Palliation of Malignant Gastric Outlet Obstruction. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1295-1302.e1. doi: 10.1016/j.cgh.2018.10.042. Epub 2018 Oct 31.

Reference Type BACKGROUND
PMID: 30391433 (View on PubMed)

Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002 Jan;97(1):72-8. doi: 10.1111/j.1572-0241.2002.05423.x.

Reference Type BACKGROUND
PMID: 11808972 (View on PubMed)

Dormann A, Meisner S, Verin N, Wenk Lang A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy. 2004 Jun;36(6):543-50. doi: 10.1055/s-2004-814434.

Reference Type BACKGROUND
PMID: 15202052 (View on PubMed)

van Hooft JE, Dijkgraaf MG, Timmer R, Siersema PD, Fockens P. Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study. Scand J Gastroenterol. 2010 Oct;45(10):1217-22. doi: 10.3109/00365521.2010.487916.

Reference Type BACKGROUND
PMID: 20459356 (View on PubMed)

Staub J, Siddiqui A, Taylor LJ, Loren D, Kowalski T, Adler DG. ERCP performed through previously placed duodenal stents: a multicenter retrospective study of outcomes and adverse events. Gastrointest Endosc. 2018 Jun;87(6):1499-1504. doi: 10.1016/j.gie.2018.01.040. Epub 2018 Feb 6.

Reference Type BACKGROUND
PMID: 29425886 (View on PubMed)

Mutignani M, Tringali A, Shah SG, Perri V, Familiari P, Iacopini F, Spada C, Costamagna G. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy. 2007 May;39(5):440-7. doi: 10.1055/s-2007-966327.

Reference Type BACKGROUND
PMID: 17516351 (View on PubMed)

Ruggiero J, Manzini G, Quadrifoglio F. Ionic and nonionic contributions to the free-energy change in the B-Z transition of alternating polydeoxynucleotides in aqueous solution. Biopolymers. 1987 Nov;26(11):1975-9. doi: 10.1002/bip.360261112. No abstract available.

Reference Type BACKGROUND
PMID: 3689879 (View on PubMed)

Kim CG, Choi IJ, Lee JY, Cho SJ, Park SR, Lee JH, Ryu KW, Kim YW, Park YI. Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc. 2010 Jul;72(1):25-32. doi: 10.1016/j.gie.2010.01.039. Epub 2010 Apr 9.

Reference Type BACKGROUND
PMID: 20381802 (View on PubMed)

Kim JH, Song HY, Shin JH, Choi E, Kim TW, Jung HY, Lee GH, Lee SK, Kim MH, Ryu MH, Kang YK, Kim BS, Yook JH. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc. 2007 Aug;66(2):256-64. doi: 10.1016/j.gie.2006.12.017.

Reference Type BACKGROUND
PMID: 17643698 (View on PubMed)

Jang JK, Song HY, Kim JH, Song M, Park JH, Kim EY. Tumor overgrowth after expandable metallic stent placement: experience in 583 patients with malignant gastroduodenal obstruction. AJR Am J Roentgenol. 2011 Jun;196(6):W831-6. doi: 10.2214/AJR.10.5861.

Reference Type BACKGROUND
PMID: 21606277 (View on PubMed)

Sasaki T, Isayama H, Nakai Y, Takahara N, Hamada T, Mizuno S, Mohri D, Yagioka H, Kogure H, Arizumi T, Togawa O, Matsubara S, Ito Y, Yamamoto N, Sasahira N, Hirano K, Toda N, Tada M, Koike K. Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstruction. Dig Endosc. 2015 Jan;27(1):37-43. doi: 10.1111/den.12321. Epub 2014 Aug 28.

Reference Type BACKGROUND
PMID: 24995858 (View on PubMed)

Ly J, O'Grady G, Mittal A, Plank L, Windsor JA. A systematic review of methods to palliate malignant gastric outlet obstruction. Surg Endosc. 2010 Feb;24(2):290-7. doi: 10.1007/s00464-009-0577-1. Epub 2009 Jun 24.

Reference Type BACKGROUND
PMID: 19551436 (View on PubMed)

Mehta S, Hindmarsh A, Cheong E, Cockburn J, Saada J, Tighe R, Lewis MP, Rhodes M. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006 Feb;20(2):239-42. doi: 10.1007/s00464-005-0130-9. Epub 2005 Dec 9.

Reference Type BACKGROUND
PMID: 16362479 (View on PubMed)

Yamao K, Kitano M, Kayahara T, Ishida E, Yamamoto H, Minaga K, Yamashita Y, Nakajima J, Asada M, Okabe Y, Osaki Y, Chiba Y, Imai H, Kudo M. Factors predicting through-the-scope gastroduodenal stenting outcomes in patients with gastric outlet obstruction: a large multicenter retrospective study in West Japan. Gastrointest Endosc. 2016 Nov;84(5):757-763.e6. doi: 10.1016/j.gie.2016.03.1498. Epub 2016 Apr 4.

Reference Type BACKGROUND
PMID: 27055762 (View on PubMed)

Hori Y, Naitoh I, Hayashi K, Ban T, Natsume M, Okumura F, Nakazawa T, Takada H, Hirano A, Jinno N, Togawa S, Ando T, Kataoka H, Joh T. Predictors of outcomes in patients undergoing covered and uncovered self-expandable metal stent placement for malignant gastric outlet obstruction: a multicenter study. Gastrointest Endosc. 2017 Feb;85(2):340-348.e1. doi: 10.1016/j.gie.2016.07.048. Epub 2016 Jul 27.

Reference Type BACKGROUND
PMID: 27475489 (View on PubMed)

Sato T, Hara K, Mizuno N, Hijioka S, Imaoka H, Niwa Y, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Bhatia V, Kobayashi N, Endo I, Maeda S, Nakajima A, Kubota K, Yamao K. Gastroduodenal stenting with Niti-S stent: long-term benefits and additional stent intervention. Dig Endosc. 2015 Jan;27(1):121-9. doi: 10.1111/den.12300. Epub 2014 Apr 22.

Reference Type BACKGROUND
PMID: 24754262 (View on PubMed)

Fritscher-Ravens A, Mosse CA, Mills TN, Mukherjee D, Park PO, Swain P. A through-the-scope device for suturing and tissue approximation under EUS control. Gastrointest Endosc. 2002 Nov;56(5):737-42. doi: 10.1067/mge.2002.129084.

Reference Type BACKGROUND
PMID: 12397289 (View on PubMed)

Fritscher-Ravens A, Mosse CA, Mukherjee D, Mills T, Park PO, Swain CP. Transluminal endosurgery: single lumen access anastomotic device for flexible endoscopy. Gastrointest Endosc. 2003 Oct;58(4):585-91. doi: 10.1016/s0016-5107(03)02006-6.

Reference Type BACKGROUND
PMID: 14520300 (View on PubMed)

Binmoeller KF, Shah JN. Endoscopic ultrasound-guided gastroenterostomy using novel tools designed for transluminal therapy: a porcine study. Endoscopy. 2012 May;44(5):499-503. doi: 10.1055/s-0032-1309382. Epub 2012 Apr 24.

Reference Type BACKGROUND
PMID: 22531985 (View on PubMed)

Amin S, Sethi A. Endoscopic Ultrasound-Guided Gastrojejunostomy. Gastrointest Endosc Clin N Am. 2017 Oct;27(4):707-713. doi: 10.1016/j.giec.2017.06.009.

Reference Type BACKGROUND
PMID: 28918806 (View on PubMed)

Irani S, Baron TH, Itoi T, Khashab MA. Endoscopic gastroenterostomy: techniques and review. Curr Opin Gastroenterol. 2017 Sep;33(5):320-329. doi: 10.1097/MOG.0000000000000389.

Reference Type BACKGROUND
PMID: 28767501 (View on PubMed)

Itoi T, Itokawa F, Uraoka T, Gotoda T, Horii J, Goto O, Moriyasu F, Moon JH, Kitagawa Y, Yahagi N. Novel EUS-guided gastrojejunostomy technique using a new double-balloon enteric tube and lumen-apposing metal stent (with videos). Gastrointest Endosc. 2013 Dec;78(6):934-939. doi: 10.1016/j.gie.2013.09.025.

Reference Type BACKGROUND
PMID: 24237949 (View on PubMed)

Itoi T, Ishii K, Tanaka R, Umeda J, Tonozuka R. Current status and perspective of endoscopic ultrasonography-guided gastrojejunostomy: endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy (with videos). J Hepatobiliary Pancreat Sci. 2015 Jan;22(1):3-11. doi: 10.1002/jhbp.148. Epub 2014 Aug 24.

Reference Type BACKGROUND
PMID: 25155270 (View on PubMed)

Itoi T, Ishii K, Ikeuchi N, Sofuni A, Gotoda T, Moriyasu F, Dhir V, Teoh AY, Binmoeller KF. Prospective evaluation of endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy bypass (EPASS) for malignant gastric outlet obstruction. Gut. 2016 Feb;65(2):193-5. doi: 10.1136/gutjnl-2015-310348. Epub 2015 Aug 17. No abstract available.

Reference Type BACKGROUND
PMID: 26282674 (View on PubMed)

Anastosatu C, Dutu S. [Contribution of pulmonary function tests to pneumonology. Report]. Ftiziologia. 1973 Jan-Feb;22(1):1-8. No abstract available. Romanian.

Reference Type BACKGROUND
PMID: 4690188 (View on PubMed)

Fan W, Tan S, Wang J, Wang C, Xu H, Zhang L, Liu L, Fan Z, Tang X. Clinical outcomes of endoscopic ultrasound-guided gastroenterostomy for gastric outlet obstruction: a systematic review and meta-analysis. Minim Invasive Ther Allied Technol. 2022 Feb;31(2):159-167. doi: 10.1080/13645706.2020.1792500. Epub 2020 Jul 16.

Reference Type BACKGROUND
PMID: 32672479 (View on PubMed)

Barthet M, Binmoeller KF, Vanbiervliet G, Gonzalez JM, Baron TH, Berdah S. Natural orifice transluminal endoscopic surgery gastroenterostomy with a biflanged lumen-apposing stent: first clinical experience (with videos). Gastrointest Endosc. 2015 Jan;81(1):215-8. doi: 10.1016/j.gie.2014.09.039.

Reference Type BACKGROUND
PMID: 25527056 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R-2020-3601-298

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.